Home Cart Sign in  
Chemical Structure| 14003-96-4 Chemical Structure| 14003-96-4

Structure of 4μ8C
CAS No.: 14003-96-4

Chemical Structure| 14003-96-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4μ8C (IRE1 Inhibitor III) functions as a small-molecule inhibitor targeting IRE1α.

Synonyms: IRE1 Inhibitor III

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 4μ8C

CAS No. :14003-96-4
Formula : C11H8O4
M.W : 204.18
SMILES Code : O=CC1=C(O)C=CC2=C1OC(C=C2C)=O
Synonyms :
IRE1 Inhibitor III
MDL No. :MFCD12027255
InChI Key :RTHHSXOVIJWFQP-UHFFFAOYSA-N
Pubchem ID :12934390

Safety of 4μ8C

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of 4μ8C

RTK
GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
FL-DCs 50 µM 5 h Inhibition of IRE1α endonuclease activity, reducing the production of IL-12p40 PMC6338037
U2OS cells 30 μM Inhibits IRE1 RNAse activity but does not affect TBEV infectivity PMC6715738
16HBE cells 30 μM Inhibits IRE1-mediated XBP1 mRNA splicing PMC4471080
K562 cells 32 μM 20 h Inhibiting the IRE1 signaling pathway protected cells from palmitate-mediated lipotoxicity PMC7696670
FL-DCs 20 µM 2 h Inhibition of IRE1α endonuclease activity, reducing the production of pro-inflammatory cytokines IL-6, TNF-α, and IL-10 PMC6338037
Primary rat β-cells 25 µM 24 h 4μ8C inhibited the IRE1-JNK signaling pathway, reducing DP5 expression and thereby decreasing palmitate-induced β-cell apoptosis. PMC3478544
INS-1E cells 25 µM 16 h 4μ8C effectively blocked IRE1, significantly reducing JNK phosphorylation and DP5 expression, thereby partially protecting β-cells from palmitate-induced apoptosis. PMC3478544
Bone marrow-derived macrophages (BMDMs) 100 μM 1 h To evaluate the effect of IRE1 RNase inhibitor 4μ8C on LCWE-induced NLRP3 inflammasome activation and IL-1β secretion. Results showed that 4μ8C treatment decreased IL-1β and Casp-1 secretion. PMC8986066
3T3-L1 adipocytes 30 or 60 μM 1 h Inhibited IRE1 RNase activity but did not reduce lipolysis PMC8010698

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice LCWE-induced Kawasaki disease vasculitis model Intraperitoneal injection 10 mg/kg Once daily, starting 2 days before LCWE injection until day 7 after LCWE injection To evaluate the effect of IRE1 RNase inhibitor 4μ8C on LCWE-induced cardiovascular lesions. Results showed that 4μ8C treatment reduced heart inflammation and the development of abdominal aorta dilations, and decreased Casp-1 activity. PMC8986066
Mice High-fat diet-induced metabolic abnormalities model Intraperitoneal injection 10 mg/kg Once daily for one week Inhibit IRE1 activity and restore SIRT1 expression and metabolic functions PMC8762396

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.90mL

0.98mL

0.49mL

24.49mL

4.90mL

2.45mL

48.98mL

9.80mL

4.90mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories